Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-02-01
著者
-
Hirano Tsutomu
Division Of Diabetes Metabolism And Endocrinology Department Of Medicine Showa University School Of
-
Morita Ryo
First Department Of Internal Medicine Showa University School Of Medicine
-
Lee Soushou
First Department Of Internal Medicine Showa University School Of Medicine
-
Seino Yutaka
Department Of Cardiology Kansai Electric Power Hospital
-
Takada Michiya
First Department Of Internal Medicine Showa University School Of Medicine
-
Hirano Tsutomu
Department Of Diabetes Metabolism And Endocrinology Showa University School Of Medicine
-
TAKADA Michiya
Department of Diabetes, Metabolism, and Endocrinology, Showa University, School of Medicine
-
LEE Soushou
Department of Diabetes, Metabolism, and Endocrinology, Showa University, School of Medicine
-
Seino Yutaka
Department Of Medicine Kansai Electric Power Hospital
-
YABE DAISUKE
Department of Medicine, Kansai Electric Power Hospital
-
NOHTOMI KYOKO
Department of Diabetes, Metabolism, and Endocrinology, Showa University
-
MORITA RYOU
Department of Diabetes, Metabolism, and Endocrinology, Showa University
-
Yabe Daisuke
Department Of Medicine Kansai Electric Power Hospital
-
Nohtomi Kyoko
Department Of Diabetes Metabolism And Endocrinology Showa University
-
Lee Soushou
Department Of Diabetes Metabolism And Endocrinology Showa University
-
Hirano Tsutomu
Department Of Diabetes Metabolism And Endocrinology Showa University
-
Takada Michiya
Department Of Diabetes Metabolism And Endocrinology Showa University
関連論文
- Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
- PJ-167 Remarkably High Levels of Small LDL-cholesterol in Younger Patients with Acute Coronary Syndrome and Metabolic Syndrome(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PE-502 Not LDL-Cholesterol But Apolipoprotein A1 is an Important Risk Marker for Severe Coronary Atherosclerosis in Patients Treated with Lipid-lowering Drugs(Atherosclerosis, clinical(08)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of
- 2 High Levels of Small Dense LDL-cholesterol as Atherogenic and Metabolic LDL in Patients with Acute Coronary Syndrome(Symposium 3 (SY-03) (IHD) Metabolic Syndrome and Atherosclerosis,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circ
- PJ-167 Remarkably High Levels of Small LDL-cholesterol in Younger Patients with Acute Coronary Syndrome and Metabolic Syndrome(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PE-502 Not LDL-Cholesterol But Apolipoprotein A1 is an Important Risk Marker for Severe Coronary Atherosclerosis in Patients Treated with Lipid-lowering Drugs(Atherosclerosis, clinical(08)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of
- 2 High Levels of Small Dense LDL-cholesterol as Atherogenic and Metabolic LDL in Patients with Acute Coronary Syndrome(Symposium 3 (SY-03) (IHD) Metabolic Syndrome and Atherosclerosis,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circ
- 2 Prolonged Postischemic Regional Left Ventricular Delayed Relaxation or Diastolic Stunning in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Angioplasty(Frontiers in Diagnostic Echocardiography,Symposium 14 (SY-14) (M),The 73rd An
- Increased Plasma Urotensin-II and Carotid Atherosclerosis are Associated with Vascular Dementia
- Postprandial Changes in LDL Phenotypes in Patients with Myocardial Infarction(Atherosclerosis, Clinical 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)